Carmen Sandi
10Patents
6h-index
11Co-inventors
59Inventor score
Filing activity: Dec 23, 2011 → Jul 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9872850B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 12 | Active |
| US10485782B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 10 | Active |
| US10028932B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US10857126B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 8 | Active |
| US11234960B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11166937B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11903922B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US12036205B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US12310943B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US10596137B2 | Medium chain fatty acids and their triglycerides for treating anxiety | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.